JRSS JRSIS HEALTH CARE Corp
Services-Hospitals · OTC · SEC CIK 1597892 · Fiscal year ends 12/31
Financial factors as of 2024-09-30 (2024Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-100.5%
TTM EPS YoY-100.1%
Revenue 3-yr CAGR-52.4%
Net income 3-yr CAGR—
Margins
Gross margin9.4%
Operating margin-7.0%
Net margin-3.7%
FCF margin—
EBITDA margin-6.4%
Returns
ROE-125.7%
ROA-13.2%
ROIC (approx.)-171.2%
Asset turnover3.58x
Leverage & solvency
Liabilities / assets111.3%
Debt / equity—
Current ratio0.78x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.67x
Accruals ratio8.8%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 | FY20202020-12-31 | FY20192019-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $3.46M | $1.72M | $44.39M | $35.71M | $31.46M |
| Cost of revenue | $2.98M | $1.69M | — | — | — |
| Gross profit | $483,051 | $26,211 | — | — | — |
| R&D expense | $189,266 | $283,043 | — | — | — |
| SG&A expense | $336,049 | $283,293 | — | — | — |
| Operating income | -$188,598 | -$684,776 | -$103,801 | $5.59M | $4.67M |
| Interest expense | $56,443 | $64,709 | $1.38M | $1.14M | $1.11M |
| Pretax income | -$85,613 | -$673,260 | -$103,801 | $5.20M | $1.93M |
| Income tax | $8,975 | — | $1.18M | $1.37M | $657,699 |
| Net income | -$80,912 | -$575,839 | $3.19M | $3.83M | $888,061 |
| EBITDA | -$134,783 | -$649,873 | $3.21M | $8.29M | $6.88M |
| EPS (basic) | -0.00 | -0.01 | 0.17 | 0.15 | 0.05 |
| EPS (diluted) | -0.00 | -0.01 | 0.17 | 0.15 | 0.05 |
| Weighted avg. shares (diluted) | 77.25M | 61.33M | 18.66M | 18.27M | 16.78M |
| Balance sheet | |||||
| Cash & equivalents | $118,114 | $158,813 | $73,253 | $844,827 | $1.97M |
| Receivables | $714,658 | $683,452 | $7.54M | $4.39M | $4.58M |
| Inventory | $455,240 | $562,015 | $1.77M | $1.46M | $1.07M |
| Current assets | $1.83M | $1.66M | $13.87M | $7.88M | $9.51M |
| PP&E, net | $50,024 | $62,223 | $33.16M | $31.46M | $22.84M |
| Intangibles | $257,334 | $303,195 | — | — | — |
| Total assets | $2.14M | $2.04M | $75.69M | $58.80M | $51.63M |
| Current liabilities | $2.28M | $2.11M | $17.60M | $11.76M | $10.92M |
| Short-term debt | $18,713 | $49,709 | — | — | — |
| Long-term debt | $24,950 | — | — | — | — |
| Total debt | $43,663 | — | — | — | — |
| Total liabilities | $2.31M | $2.11M | $42.59M | $29.96M | $28.64M |
| Shareholders' equity | -$137,406 | -$58,453 | $33.10M | $19.04M | $14.82M |
| Net debt | -$74,451 | — | — | — | — |
| Shares outstanding | 82.59M | 76.76M | 18.63M | 18.25M | 17.98M |
| Cash flow statement | |||||
| Operating cash flow | $516,724 | -$1.76M | $8.23M | $10.64M | $11.85M |
| Capital expenditure | $1,484 | $44,644 | $2.31M | $8.27M | $4.71M |
| Free cash flow | $515,240 | -$1.81M | $5.93M | $2.37M | $7.13M |
| Investing cash flow | $18,885 | -$2.83M | -$5.50M | -$8.27M | -$3.96M |
| Financing cash flow | -$568,365 | $1.86M | -$2.80M | -$3.43M | -$6.11M |
| Depreciation & amortization | $53,815 | $34,903 | $3.31M | $2.70M | $2.21M |
| Stock-based compensation | — | $245,465 | — | — | — |
Free plan shows the latest 5 periods; Pro shows all 11 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.